Rite Aid

Rite Aid Corp. engages in the ownership and management of retail drug stores. It operates through following segments: Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment includes branded and generic prescription drugs, health and beauty aids, personal care products, and walk-in retail clinics. The Pharmacy Services segment offers transparent and traditional pharmacy benefit management for insurance companies, employers, health plans, and government employee groups. The company was founded by Alex Grass on September 12, 1962 and is headquartered in Philadelphia, PA.

Earnings data Q1 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Rite Aid is a drugstore chain that offers prescription medications, over-the-counter drugs, and health and wellness products. Rite Aid is reshaping the concept of a modern pharmacy by catering to customer demands through various convenient channels, including retail and delivery pharmacy services. Additionally, the company's offerings extend to services provided by its wholly-owned subsidiaries, namely Elixir, Bartell Drugs, and Health Dialog. Elixir, Rite Aid’s pharmacy benefits and services company, encompasses accredited mail and specialty pharmacies, prescription discount programs, and an advanced adjudication platform. These components combine to provide exceptional member experiences and substantial cost savings. Furthermore, Health Dialog delivers healthcare coaching and disease management services through interactive live online sessions and phone-based health services.

Rite Aid is a health products and services company with 2,400 locations across 17 states.

The company's omnichannel business includes digital, retail, and delivery touchpoints. Rite Aid is a top 20 seller of speciality medications, per its investor website.

In addition to its retail business, Rite Aid owns a pharmacy benefits subdivision (Elixir) and a personalized health services and coaching arm, Health Dialog, which has served 10MM members as of May 2022.

The company has reported $1.85 billion of liquidity with no debt maturities until 2025. According to its investor website, Rite Aid expects to be free cash flow (FCF) positive in FY23.

In Q2 2022, Rite Aid shared a three-part growth strategy aimed at deepening market share, expanding into new markets, and creating new offerings.

To grow the current business, Rite Aid is aiming to increase its e-commerce and digital sales, refresh its loyalty program, and grow its specialty pharmacy offering, which focuses on serving customers with complex health conditions.

New market expansion plans include increasing Rite Aid's footprint of "small format" pharmacies in underserved communities and implementing "store within a store" partnerships.

Rite Aid also aims to grow via new offerings, such as expanded health plan and health system clinical services, a pharmacy benefit manager (PBM) as a service offering, and new strategic partnerships.

Rite Aid Investor Relations

*This is not investment advice.

Rite Aid (NYSE: RAD ) stock is falling on Monday following reports that the pharmaceutical company is preparing to file for bankruptcy. According to these reports, Rite Aid is getting ready to file for bankruptcy in the near future.

Why Is Rite Aid (RAD) Stock Down Today?

Shares of 3M Co. MMM, +0.46% rose 4.6% in premarket trading after The Wall Street Journal reported that the multinational conglomerate was nearing agreement on a $5.5 billion plan to settle more than 300,000 lawsuits over defective military earplugs.

3M shares climb on lawsuit settlement update, while Rite Aid drops on bankruptcy reports and other moving shares

Hostess Brands

A pair of classic American brands had opposite days Friday as shares of one soared to their best day ever on reports of a possible sale, while the other's stock suffered its worst performance on record after a report of a pending bankruptcy.

Twinkies and Snoballs parent Hostess scores best stock day ever on deal buzz; Rite Aid suffers its worst

What a day it's been for shareholders in Rite Aid (NYSE: RAD ). Shares of RAD stock sank more than 50% in today's session as investors priced in some rather bleak news.

RAD Stock Alert: Rite Aid Plunges on the Brink of Bankruptcy

Rite Aid, one of the biggest pharmacy chains in the country, is preparing to file for Chapter 11 bankruptcy protection in coming weeks, according to a new report.

Rite Aid prepares to file for bankruptcy: report

Rite Aid Corp. RAD, -52.78% shares dropped Friday following a report that the drugstore chain was filing for chapter 11 bankruptcy protection because of opioid lawsuits. Rite Aid shares dropped more than 50% to an intraday low of 66 cents a share after the Wall Street Journal reported the company was filing to cover more than $3.3 billion in debt amid lawsuits that allege the drugstore chain overprescribed opioid painkillers, citing people familiar with the plans.

Rite Aid's stock drops more than 50% on pending chapter 11 bankruptcy: WSJ

Rite Aid could become the latest company to declare bankruptcy as a result of lawsuits filed in the wake of the opioid crisis.

Rite Aid Reportedly Preparing For Bankruptcy Amid Opioid Lawsuits And $3.3 Billion Debt

The Chapter 11 filing would cover Rite Aid's more than $3.3 billion debt load and pending legal allegations that it oversupplied prescription painkillers, the Journal reported.

Rite Aid reportedly prepares to file for bankruptcy to shield it from opioid lawsuits

Rite Aid Corp is preparing to file for bankruptcy in coming weeks to address lawsuits the company is facing over its alleged role in the sale of opioids, the Wall Street Journal reported on Friday, citing people familiar with the plan.

Drug retailer Rite Aid prepares to file for bankruptcy - WSJ

Kroger

Walmart

Analysts said blockbuster weight loss drugs like Wegovy are minimally profitable for retailers like Walmart – and may even come with slight margin headwinds.

Weight loss drugs boost sales at retail pharmacies, but they may not help profits much

T2 Biosystems

Earlier this week, InvestorPlace's Thomas Yeung posed an interesting question: Could Rite Aid (NYSE: RAD ) become the next big meme stock? As meme stocks surged last week, The Wall Street Journal flagged the struggling pharmaceutical chain as a likely contender for the next r/WallStreetBets favorite.

TTOO vs. RAD Stock: Which New Meme Stock Is the Worst Buy?

Last week, meme investors “discovered” Rite Aid (NYSE: RAD ), sending its shares up 70%. The Wall Street Journal would quickly give the company a meme stock crown.

Could Rite Aid Become the Next AMC Meme Stock?

Shares of Rite Aid (NYSE: RAD ) stock are bouncing higher on Friday, up about 5.5% at the moment. At today's high, RAD stock was up roughly 23%.

Rite Aid Short Squeeze Takes RAD Stock 6% Higher

Cano Health

Globalstar

Retail investors are on the prowl for the best penny stocks to invest in. We've touched on several unique trends currently influencing the stock market, including sentiment-driven sympathy trades.

Best Penny Stocks To Buy? 3 To Watch With Unusual Options Action

Rite Aid has not had a profitable year since 2018. The company reported a loss of $306 million in its last quarterly report.

Why Shares of Rite Aid Soared This Week

Yesterday, Rite Aid (NYSE: RAD ) stock had its best day since 2019 after being identified as a short squeeze. Shares in the pharmacy chain rose over 31% after Fintel reported that 23% of the company's stock was being held short, and 51% of its off-exchange volume was short.

Is a Giant Short Squeeze Brewing in Rite Aid (RAD) Stock?

Ardelyx

CM Life Sciences III

Penny stocks are an interesting asset class. On any given day, you will see at least a handful experiencing extreme levels and explosive moves.

Best Penny Stocks To Watch After Fitch Downgrade? 3 For Your List

PHILADELPHIA--(BUSINESS WIRE)--Rite Aid (NYSE: RAD) today published its fifth annual Environmental, Social and Governance (ESG) Report, detailing the company's initiatives, focus areas, and progress over the past year. The four ESG pillars introduced in the 2021 report – Thriving Planet, Thriving Business, Thriving Workplace and Thriving Community – continue to act as the lens through which Rite Aid approaches its ESG commitments, and the disclosure in the voluntary report is intended to align.

Rite Aid Shares Progress on Environmental, Social and Governance Efforts in Fifth Annual Report

CVS Health

Herbalife

The Zacks Retail Pharmacy and Drugstore industry players like CVS, HLF and RAD are likely to gain despite reimbursement challenges hurting the overall industry health.

3 Retail Pharmacy and Drugstore Stocks to Watch Amid Industry Headwinds

PHILADELPHIA--(BUSINESS WIRE)--Getting vaccinated can be a family affair. Rite Aid (NYSE: RAD) will offer Back to School Family Immunization Days at select stores, including Bartell Drugs in the Pacific Northwest, providing families convenient opportunities to walk in and get the vaccinations they need to protect themselves against measles, whooping cough, COVID-19, and other diseases. Rite Aid Family Immunization Days are walk-in clinics available to families providing convenient opportunities.

Rite Aid Offering Back to School Family Immunization Days

Despite drab demand and headwinds at Elixir Insurance, Rite Aid's (RAD) solid online show, strength in the Retail Pharmacy segment and cost-saving initiatives are likely to aid growth.

Can Rite Aid (RAD) Stock Bounce Back on Growth Endeavors?

Rite Aid executives aren't ruling out more store closures as the company sustains more financial losses while they're working their turnaround plan.

Rite Aid Not Ruling Out More Store Closures As Losses Mount

Shares of Rite Aid NYSE: RAD have been on a sluggish path to becoming a near-penny stock, despite being one of the most entrenched brands in American Households. This name has become synonymous with children's 'boo boos' and first-aid kits.

Rite Aid Could Become An Acquisition Target

During its fiscal first quarter, Rite Aid reported a boost in pharmacy sales, attributed to the introduction of a new category of drugs.  Pharmacy sales rose 3.4% year over year, fueled by the demand for Ozempic and other GLP-1 receptor agonists.

Rite Aid Rides Ozempic Wave but Fails to Profit

Rite Aid's (RAD) Q1 results gain from solid pharmacy margins and progress in its turnaround program. Lower revenues from COVID-19 vaccines and testing, and store closures are headwinds.

News for Rite Aid Stock (RAD)